Mosunetuzumab User Reviews & Ratings
Brand names: Lunsumio
Mosunetuzumab has an average rating of 8.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Follicular Lymphoma | 1 reviews for Follicular Lymphoma | 17 medications |
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about mosunetuzumab
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
For Follicular Lymphoma "I've had 4 treatments, 1mg, 2mg, and 2 - 60mg. I've been extremely tired after the two 60mg treatments. Unable to stand without assistance for a few days after treatment. Could not read or comprehend my daily readings. After 12 days from my last treatment, I am just now beginning to be able to take walks and short hikes. I intend to take two more 30mg treatments and then stop so I can enjoy a two-week trip to Hawaii. Upon returning in mid-June, I will meet with my oncologist and the City of Hope doctors for further evaluation and treatment."